Pasithea Therapeutics' Board Authorizes Share Repurchase Program Through $4 Million Tender Offer; Shares Rise

MT Newswires ·  07/20/2023 22:44
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment